About
Filterlex Medical Ltd. is a medical technology company based in Israel that focuses on developing advanced full-body embolic protection devices (EPDs). These devices are designed to reduce the risk of stroke and other complications during catheter-based structural heart procedures, particularly transcatheter aortic valve replacement (TAVR) and other left heart interventions. The company's flagship product, the CAPTIS® intra-aortic embolic protection device, is engineered to be securely positioned in the aorta. It deflects, captures, and removes embolic particles generated during cardiac procedures, aiming to prevent debris from reaching the brain and other vital organs. The CAPTIS device has shown promising results in clinical evaluations, including a first-in-human study that demonstrated a 100% success rate in deployment and effective capture of embolic debris. Filterlex Medical targets hospitals, cardiovascular surgeons, and interventional cardiologists, providing innovative solutions to enhance patient safety and outcomes in complex cardiac interventions.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2015
-
Total Funding $19202143
Location
Khalamish Street, Caesarea, Haifa District, Israel
